Template talk:Adrenergic receptor modulators
|
| This template is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology articles | |
|
| This template is within the scope of WikiProject Chemicals, a daughter project of WikiProject Chemistry, which aims to improve Wikipedia's coverage of chemicals. To participate, help improve this template or visit the project page for details on the project.ChemicalsWikipedia:WikiProject ChemicalsTemplate:WikiProject Chemicalschemicals articles | |
|
|
Very large template
This template seems to be rather large and therefore confusing. Couldn't it be split somehow? --ἀνυπόδητος (talk) 17:31, 9 October 2009 (UTC)
Labetalol
In this template this drugs would act as agonist and antagonist; since its role as Beta-blocker, I would correct it.
Emigiorg (talk) 14:36, 31 July 2012 (UTC)
Thanks for correcting that error! --
ἀνυπόδητος (
talk) 17:46, 31 July 2012 (UTC)
Semi-protected edit request on 15 September 2014
NikoGoro (talk) 05:22, 15 September 2014 (UTC)
Done
Anon126 (
notify me of responses! /
talk /
contribs) 05:50, 15 September 2014 (UTC)
Semi-protected edit request on 28 April 2015
B2-agonist Olodaterol
NikoGoro (talk) 07:34, 28 April 2015 (UTC)
Not done: it's not clear what changes you want to be made. Please mention the specific changes in a "change X to Y" format.
EoRdE6(
Come Talk to Me!) 14:44, 28 April 2015 (UTC)
Semi-protected edit request on 16 December 2015
Xylometazoline is a α1 agonist too.
193.233.52.241 (talk) 08:24, 16 December 2015 (UTC)
Added
Seppi333 (
Insert 2¢) 09:44, 16 December 2015 (UTC)